tiprankstipranks
Trending News
More News >
Poniard Pharmaceuticals (PARD)
OTHER OTC:PARD
US Market
Advertisement

Poniard Pharmaceuticals (PARD) Income Statement

Compare
7 Followers

Poniard Pharmaceuticals Income Statement

Last quarter (Q0 0), Poniard Pharmaceuticals's total revenue was $―, a decrease of ― from the same quarter last year. In Q0, Poniard Pharmaceuticals's net income was $-3.77M. See Poniard Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 10Dec 09Dec 08Dec 07Dec 06
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 0.00$ 0.00$ 0.00$ ―$ ―
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ ―$ ―$ ―$ ―
EBITDA
$ -25.02M$ -38.97M$ -47.55M$ -34.22M$ -17.02M
Operating Income
$ -26.33M$ -40.44M$ -49.16M$ -35.35M$ -21.23M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -30.05M$ -45.72M$ -48.56M$ -32.78M$ -23.29M
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Poniard Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis